|

Price Advances Leaders: INHX, AYI, RL, NFLX, VRUS, FFIV

Price Advances Leaders: INHX, AYI, RL, NFLX, VRUS, FFIV

Inhibitex, Inc. (Public, NASDAQ:INHX) percentage change (141.84%), to its trade at $23.87 and its overall traded volume was 24.74M shares during the last session against its average 30 day volume of 3.25M. The stock has a 52-week range of $24.08-$2.15. At current market price, the market capitalization of the company stands at 1.87B and it has 78.29M outstanding shares. Inhibitex, Inc.is a biopharmaceutical company focused on the development of differentiated anti-infective products to prevent or treat serious infections. The Company’s research and development efforts are focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by Hepatitis C Virus (HCV) and herpes zoster, which is caused by the varicella zoster virus (VZV). The Company’s anti-infective product candidates include INX-189, HCV Nucleotide Polymerase Inhibitors, FV-100, Staphylococcal Vaccines and Aurexis.

Acuity Brands, Inc. (Public, NYSE:AYI) percentage change (12.76%), to its trade at $56.74 and its overall traded volume was 736,044.00 shares during the last session against its average 30 day volume of 304,630.00. The stock has a 52-week range of $61.45-$33.13. At current market price, the market capitalization of the company stands at 2.39B and it has 42.06M outstanding shares. Acuity Brands, Inc. (Acuity Brands) is the parent company of Acuity Brands Lighting, Inc. (ABL), and other subsidiaries. The Company is a provider of lighting fixtures, control devices, components, systems and services for commercial and institutional, industrial, infrastructure, and residential applications for various markets throughout North America and select international markets. Acuity Brands designs, produces, and distributes a range of indoor and outdoor lighting and control systems for commercial and institutional, industrial, infrastructure, and residential applications. The Company manufactures or procures lighting products primarily in North America, Europe, and Asia. These products and related services are marketed under numerous brand names. As of August 31, 2010, the Company manufactured products in 14 plants in North America and two plants in Europe. On October 14, 2010, the Company acquired all of Winona Lighting, Inc. In August 2011, it acquired Horizon Control Inc.

Ralph Lauren Corp (Public, NYSE:RL) percentage change (4.17%), to its trade at $146.57 and its overall traded volume was 756,890.00 shares during the last session against its average 30 day volume of 884,120.00. The stock has a 52-week range of $164.55-$102.33. At current market price, the market capitalization of the company stands at 13.50B and it has 92.13M outstanding shares. Ralph Lauren Corporation, formerly Polo Ralph Lauren Corporation, is engaged in the design, marketing and distribution of products, including men’s, women’s and children’s apparel, accessories (including footwear), fragrances and home furnishings. The Company operates in three segments: Wholesale, Retail and Licensing. Its apparel products include a range of men’s, women’s and children’s clothing. Accessories include a range of footwear, eyewear, watches, jewelry, hats, belts and leathergoods, including handbags and luggage. The Company’s coordinated home products include bedding and bath products, furniture, fabric and wallpaper, paint, tabletop and giftware. Fragrance products are sold under its Big Pony, Romance, Polo, Lauren, Safari, Ralph and Black Label brands, among others. On January 1, 2011, it acquired certain net assets (including inventory) from Doosan Corporation (Doosan). Doosan was its licensee for the Polo South Korea business.

Netflix, Inc. (Public, NASDAQ:NFLX) percentage change (5.89%), to its trade at $91.37 and its overall traded volume was 9.20M shares during the last session against its average 30 day volume of 7.06M. The stock has a 52-week range of $304.79-$62.37. At current market price, the market capitalization of the company stands at 4.80B and it has 52.50M outstanding shares. Netflix, Inc. (Netflix) is an Internet subscription service streaming television shows and movies. The Company’s subscribers can watch unlimited television shows and movies streamed over the Internet to their televisions, computers and mobile devices and in the United States, subscribers can also receive digital versatile discs (DVDs) delivered to their homes. The Company is organized into two operating segments: United States and International. The Company obtains content from various studios and other content providers through fixed-fee licenses, revenue sharing agreements and direct purchases. The Company markets its service through various channels, including online advertising, broad-based media, such as television and radio, as well as various partnerships. In September 2010, the Company began international operations by offering an unlimited streaming plan without DVDs in Canada.

Pharmasset, Inc. (Public, NASDAQ:VRUS) percentage change (3.30%), to its trade at $135.71 and its overall traded volume was 1.77M shares during the last session against its average 30 day volume of 2.05M. The stock has a 52-week range of $136.00-$22.00. At current market price, the market capitalization of the company stands at 10.27B and it has 75.66M outstanding shares. Pharmasset, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections. The Company focuses on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection. Nucleoside/tide analogs are a class of compounds, which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. The Company has three clinical-stage product candidates. It also has a series of preclinical candidates in preparation for clinical development. The three clinical product candidates include RG7128, PSI-7977 and PSI-938.

F5 Networks, Inc. (Public, NASDAQ:FFIV) percentage change (3.22%), to its trade at $110.16 and its overall traded volume was 1.05M shares during the last session against its average 30 day volume of 1.65M. The stock has a 52-week range of $145.76-$69.01. At current market price, the market capitalization of the company stands at 8.76B and it has 79.48M outstanding shares. F5 Networks, Inc. (F5 Networks) is a provider of application delivery networking (ADN) technology that optimizes the delivery of network-based applications and the security, performance and availability of servers, data storage devices and other network resources. The Company’s BIG-IP application delivery controllers (ADCs) is positioned in front of Web and application servers, balancing traffic and performing compute-intensive functions, such as encrypting and un-encrypting transmissions, screening traffic for security threats, maintaining open connections with servers, speeding the flow of traffic, managing access to applications and data. The core of its ADN technology is its full-proxy Traffic Management Operating System (TMOS). F5 Networks sells its products and services to large enterprise customers and service providers through a range of channels, including distributors, value-added resellers (VARs) and systems integrators.

Short URL: http://www.newsvindication.com/?p=4121

Posted by on Jan 9 2012. Filed under Business. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Recently Commented

  • Madonna Bio: Madonna is surely the most influental pop artist in the USA today. She’s on top…
  • lady gaga costumes: It’s actually a nice and helpful piece of info. I am glad that you shared this useful information...
  • Johnny: Why were ppl working as bartenders and servers getting checks for 50k, but those of us who waited, are...
  • Magie: This lady is such a bi* Bruce should divorce her. That is do DISRESPECTFUL. She wants to change it back...
  • Rhiannon: Taylor is amazing…’nuff said